These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 3548065)
21. [Plasma levels of kallikrein and kallikreinogen and evaluation of different methods of treating psoriasis]. Kolosovskiĭ ED Vestn Dermatol Venerol; 1983 Apr; (4):11-4. PubMed ID: 6553448 [No Abstract] [Full Text] [Related]
22. [Influence of various combinations of antitubercular agents on the course of experimental tuberculous infections and development of drug resistance]. Durisić M; Davidović C; Jovanović M; Marković Lj Glas Srp Akad Nauka Med; 1975; (26):17-23. PubMed ID: 816709 [No Abstract] [Full Text] [Related]
24. Disseminated mycobacterium bovis infection in an immunocompetent host. Schübel N; Rupp J; Gottschalk S; Zabel P; Dalhoff K Eur J Med Res; 2006 Apr; 11(4):163-6. PubMed ID: 16720281 [TBL] [Abstract][Full Text] [Related]
25. [Experimental study of secondary tuberculostatic preparations in view of the resistance of mycobacteria to the primary drugs]. Uvarova OA; Zemskova ZS; Stukalova BIa; Afanas'eva IuP Farmakol Toksikol; 1967; 30(4):474-7. PubMed ID: 4877410 [No Abstract] [Full Text] [Related]
29. [Determining dehydrogenase activity as a method of accelerated indication of the viability of Mycobacterium tuberculosis]. Vishnevskiĭ BI; Manicheva OA Probl Tuberk; 1992; (7-8):42-4. PubMed ID: 1488441 [TBL] [Abstract][Full Text] [Related]
30. [Pancreatic kallikrein, a protector of small intestine damage in post-ischemic toxemia]. Protsenko VA; Lutsik NG; Nesterov EN; Kharchenko VZ Farmakol Toksikol; 1989; 52(4):34-6. PubMed ID: 2806524 [TBL] [Abstract][Full Text] [Related]
31. [Experimental basis for using physical and enzyme therapy with terrilytin in renal tuberculosis]. Bellendir EN; Iagafarova RK Probl Tuberk; 1985; (8):63-8. PubMed ID: 2414771 [No Abstract] [Full Text] [Related]
32. [Clinical manifestations and treatment of respiratory organ tuberculosis in children caused by Mycobacterium bovis]. Niiazbekova KZh Probl Tuberk; 1985; (4):28-31. PubMed ID: 3923470 [No Abstract] [Full Text] [Related]
33. Shortening the treatment of tuberculosis. Mitchison DA Nat Biotechnol; 2005 Feb; 23(2):187-8. PubMed ID: 15696148 [No Abstract] [Full Text] [Related]
34. Mycobacterium bovis disease in a pediatric renal transplant patient. Chen SF; Gutierrez K Pediatr Infect Dis J; 2006 Jun; 25(6):564-6. PubMed ID: 16732161 [TBL] [Abstract][Full Text] [Related]
35. [Blood bacteriostatic activity in patients following administration of antituberculosis preparations and its clinical significance]. Ginzburg TS; Iashchenko TT Probl Tuberk; 1970; 48(2):73-7. PubMed ID: 4990135 [No Abstract] [Full Text] [Related]
36. [Place of bacteriological examination in the treatment of tuberculosis]. Gyselen A Acta Tuberc Pneumol Belg; 1972; 63(4):405-8. PubMed ID: 4206438 [No Abstract] [Full Text] [Related]
37. [Immunological indices of patients with destructive pulmonary tuberculosis due to bovine and human Mycobacterium tuberculosis]. Naubet'iarova AN; Syzdykova NS; Alenova AKh Probl Tuberk; 1987; (4):34-6. PubMed ID: 3110764 [No Abstract] [Full Text] [Related]
38. [Effect of neocompensan (haemodesum) on the course of experimental myocardial infarct with arrhythmias in rabbits]. Marshutina NV Farmakol Toksikol; 1978; 41(5):568-75. PubMed ID: 700080 [TBL] [Abstract][Full Text] [Related]
39. [Effect of schizophyllan in experimental tuberculosis]. Komatsu N; Nagumo N; Amemiya K; Kato M; Saga K Jpn J Antibiot; 1973 Oct; 26(5):459-69. PubMed ID: 4271543 [No Abstract] [Full Text] [Related]
40. A roadmap for drug discovery and its translation to small molecule agents in clinical development for tuberculosis treatment. Showalter HD; Denny WA Tuberculosis (Edinb); 2008 Aug; 88 Suppl 1():S3-17. PubMed ID: 18762151 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]